Mårten Wigstøl • 1960 • Oslo • 10 roles • 10 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
C COMBRA INVEST AS	Managing Director/CEO	-	-112,196	33.33 % indirectly
C CIMON MEDICAL AS	Managing Director/CEO	401,583	38,431,266	3.44 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
B BARRACUDA INVEST AS	Contact Person	1,552,992	7,113,746	100 % directly
C COMBRA INVEST AS	Board Member	-	-112,196	33.33 % indirectly
E ERAZE OSLO AS Closed	Board Member	5,935,639	-766,314	28.09 % indirectly
E ERAZE AS	Board Member	6,011,648	-495,428	28.09 % indirectly
B BRACOM AS	Chairman	155,457,798	47,016,805	18.82 % indirectly
L LYBE SCIENTIFIC AS	Chairman	4,937,610	8,842,159	4.87 % indirectly
C CIMON MEDICAL AS	Chairman	401,583	38,431,266	3.44 % indirectly

Last update: Aug 7, 2025

Related industries3

Direct relationships5

JC
Jan Christian Sølve Ohlander Fosseidbråten1972
ERAZE OSLO AS, ERAZE AS
CM
Christina Myhre Lystad1991
ERAZE OSLO AS, ERAZE AS
EG
Erling Geir Iversen1964
BRACOM AS, COMBRA INVEST AS
LA
Leif Arne Matre1962
BRACOM AS, COMBRA INVEST AS
MN
Marcus Nøstdahl1978
ERAZE OSLO AS, ERAZE AS

Shares owned by Mårten Wigstøl

Name	Share class	Total operating income	Total equity	Share
B BARRACUDA INVEST AS	Ordinære aksjer	1,552,992	7,113,746	100 % directly
C COMBRA INVEST AS		0	-112,196	33.33 % indirectly
E ERAZE OSLO AS Closed		5,935,639	-766,314	28.09 % indirectly
E ERAZE AS		6,011,648	-495,428	28.09 % indirectly
B BRACOM AS		155,457,798	47,016,805	18.82 % indirectly
B BRACOM MICROTRENCHING AS Closed		29,016,781	532,344	18.82 % indirectly
L LYBE SCIENTIFIC AS		4,937,610	8,842,159	4.87 % indirectly
K KEIMON MEDICAL AS		250,000	578,340	4.75 % indirectly
C CIMON MEDICAL AS		401,583	38,431,266	3.44 % indirectly
D DEFIBRIO AS		0	128,648,780	1.05 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025